Erratum to "Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings" [Eur J Cancer 136 (September 2020) 159-168]
1 Interdisciplinary Teragnosis and Radiosomics (INTRA) Network, Universidad de Navarra, Madrid, Spain; Medical Oncology Department, Clinica Universidad de Navarra, Madrid, Spain.
2 Interdisciplinary Teragnosis and Radiosomics (INTRA) Network, Universidad de Navarra, Madrid, Spain.
3 Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
4 Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
5 Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain. Electronic address: alberto.carmonabayonas@gmail.com.